Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 7 Results

Title
Intervention Indication Therapeutic Area Year Actions
Etrolizumab for Crohn’s Disease Etrolizumab (PRO145223; RG7413; rhuMAb Beta7) Crohn's disease Gastroenterology , Immunology 2021 View  |  Download
Filgotinib for treating moderately to severely active Crohn's disease Filgotinib (GLPG-0634; filgotinib maleate) Crohn's disease Gastroenterology , Immunology 2022 View  |  Download
Guselkumab for treating moderately to severely active Crohn’s disease Guselkumab (Tremfya; CNTO-1959) Crohn's disease Gastroenterology , Immunology 2022 View  |  Download
Mirikizumab for treating moderately to severely active Crohn’s disease Mirikizumab (LY3074828) Crohn's disease Gastroenterology , Immunology 2022 View  |  Download
Risankizumab for moderate to severe crohn’s disease Risankizumab (BI 655066; Skyrizi; ABBV 066) Crohn's disease Gastroenterology , Immunology 2021 View  |  Download
Upadacitinib for moderate to severe active Crohn’s disease Upadacitinib (ABT-494; Rinvoq; upadacitinib hemihydrate) Crohn's disease Gastroenterology , Immunology 2021 View  |  Download
Ustekinumab for the treatment of moderately to severely active Crohn's disease in children Ustekinumab (Stelara; CNTO 1275; CNTO-1275) Crohn's disease Gastroenterology , Immunology 2023 View  |  Download
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications